• 제목/요약/키워드: MST

검색결과 231건 처리시간 0.028초

New Alternative Splicing Isoform and Identification of the Kinase Activity of N-Terminal Kinase-Like Protein (NTKL)

  • Merlin, Jayalal L.P.
    • 통합자연과학논문집
    • /
    • 제6권4호
    • /
    • pp.234-243
    • /
    • 2013
  • N-terminal kinase-like (NTKL) protein was initially identified as a protein binding to protein kinase B (PKB, also known as Akt). Though NTKL-BP1 (NTKL-binding protein 1) has been identified as an NTKL binding protein, its functions related to binding have not yet been elucidated. Here, a new alternative spliced variant of NTKL and its association with integrin ${\beta}1$ is described, in addition to the kinase activity of NTKL and its substrate candidates. Although the phosphorylation of the candidates must be further confirmed using other experimental methods, the observation that NTKL can phosphorylate ROCK1, DYRK3, and MST1 indicates that NTKL may act as a signaling protein to regulate actin assembly, cell migration, cell growth, and to facilitate differentiation and development in an integrin-associated manner.

Optimal Terminal Interconnection Reconstruction along with Terminal Transition in Randomly Divided Planes

  • Youn, Jiwon;Hwang, Byungyeon
    • Journal of information and communication convergence engineering
    • /
    • 제20권3호
    • /
    • pp.160-165
    • /
    • 2022
  • This paper proposes an efficient method of reconstructing interconnections when the terminals of each plane change in real-time situations where randomly divided planes are interconnected. To connect all terminals when the terminals of each plane are changed, we usually reconstruct the interconnections between all terminals. This ensures a minimum connection length, but it takes considerable time to reconstruct the interconnection for the entire terminal. This paper proposes a solution to obtain an optimal tree close to the minimum spanning tree (MST) in a short time. The construction of interconnections has been used in various design-related areas, from networks to architecture. One of these areas is an ad hoc network that only consists of mobile hosts and communicates with each other without a fixed wired network. Each host of an ad hoc network may appear or disappear frequently. Therefore, the heuristic proposed in this paper may expect various cost savings through faster interconnection reconstruction using the given information in situations where the connection target is changing.

Optimal Terminal Interconnections Using Minimum Cost Spanning Tree of Randomly Divided Planes

  • Minkwon Kim;Yeonsoo Kim;Hanna Kim;Byungyeon Hwang
    • Journal of information and communication convergence engineering
    • /
    • 제22권3호
    • /
    • pp.215-220
    • /
    • 2024
  • This paper presents an efficient method for expanding interconnections in scenarios involving the reconstruction of interconnections across arbitrarily divided planes. Conventionally, such situations necessitate rebuilding interconnections based on all targets, ensuring minimal cost but incurring substantial time expenditure. In this paper, we present a tinkered tree algorithm designed to efficiently expand interconnections within a Euclidean plane divided into m randomly generated regions. The primary objective of this algorithm is to construct an optimal tree by utilizing the minimum spanning tree (MST) of each region, resulting in swift interconnection expansion. Interconnection construction is applied in various design fields. Notably, in the context of ad hoc networks, which lack a fixed-wired infrastructure and communicate solely with mobile hosts, the heuristic proposed in this paper is anticipated to significantly reduce costs while establishing rapid interconnections in scenarios involving expanded connection targets.

국소적으로 진행된 비소세포 폐암에 대한 과분할 방사선 치료의 성적 (The Results of Hyperfractionated Radiotherapy on Locally Advanced Non-Small Cell Lung Cancer)

  • 허원주;이형식;김정기;최영민;이호준;윤선민;김재석;김효진;우종수;최필조;이기남
    • Radiation Oncology Journal
    • /
    • 제16권3호
    • /
    • pp.275-282
    • /
    • 1998
  • 목적 : 국소적으로 진행된 병기 IIIA, IIIB 비소세포 폐암에서 과분할 방사선 치료의 효과를 알아보고자 하였다. 방법 : 1992년 10월부터 1995년 10원까지 병기결정과 병리조직 검사상 절제 불가능한 비소세포 폐암으로 확진된 환자 중 전신상태가 양호한 (ECOG score 2 이하) 61명을 대상으로 분석하였다. 방사선치료는 확진 후 2주내 시행하였으며 15 MV x-ray를 이용하여 일일 2회 (매 치료당 120 cGy) 주 5회 치료하였으며 방사선 총량은 6400-7080 cGy (중앙값 6934 cGy)가 되도록 조사하였다. 결과 : 치료후 종양의 완전관해 (CR)는 전체 61명 중 22명이었고 부분관해 (PH)가 32명에서 관찰되었으며 무반응 (NR)의 경우도 7명에서 관찰되었다. 완전관해의 경우 중앙 생존기간이 19.5개월로 부분관해의 11.7개월, 무반응의 6.3개월에 비해 높아 통계적 유의성이 있었으며 (p=0.0003), 1년 및 2년 생존율도 완전 관해군에서 70.0$\%$, 22.7$\%$로 부분관해의 46.8$\%$ 및 3.3$\%$보다 높았다. 전체 61명 환자 중 IIIA군이 29명 1110군이 32명이었고 완전 관해는 IIIA군에서 11명, IIIB군에서도 11명이었다. 각 병기에 따른 1년 및 2년 생존율은 IIIA군이 각각 63.3$\%$, 16.8$\%$이고 IIIB군이 43.3$\%$, 3.5$\%$ 로 통계적 유의성이 있었고 (p=0.043), 중앙 생존기간은 IIIA가 16.7개월, IIIB가 11.4개월이었다. 국소 치료 실패율은 양군에서 유사한 정도로 관찰되었으나 (IIIA 74.4$\%$, IIIB 75$\%$), 원격전이는 IIIB 환자가 높게 나타났다 (IIIA 24.1$\%$, IIIB 43.8$\%$). 조직학적으로도 편평상피암과 선암의 경우 국소치료 실패율은 비슷하였으나 (편평상피암 74.5$\%$, 선암71.4$\%$), 원격전이는 선암이 많았다 (편평상피암 29.8$\%$, 선암 50.0$\%$). 과분할 방사선 치료에 대한 합병증은 전체 61명 환자 중 43명에서 Grade I-II의 방사선 식도염이 관찰되었고 치료 종결후 2개월 내에 2명의 환자에서 급성 방사선 폐렴이 나타났고, 만성 방사선 폐렴은 1명에서 나타났으며 13개월만에 만성 방사선 폐렴에서 폐 섬유화가 진행되어 사망하였다. 결론 : 국소적으로 진행되어 수술 불가능한 비소세포성 폐암중 특히 IIIA의 경우 치료에 대한 독성을 감안하더라도 과분할 방사선 치료를 시도하여 완전 관해율을 향상시킴으로써 생존율 향상에 많은 도움을 줄 수 있을 것으로 사료된다.

  • PDF

육종용약침의 항암작용(抗癌作用) 및 면역효과(免疫效果)에 대(對)한 실험적(實驗的) 연구(硏究) (Study on the Anti-cancer, Anti-metastasis and Immune response improvement of Aqua-acupuncture with Cistanches Herba infusion solution)

  • 이은용;이병렬
    • Journal of Acupuncture Research
    • /
    • 제17권1호
    • /
    • pp.251-286
    • /
    • 2000
  • To study the effects of anti-cancer, anti-metastasis and immune response improvement of aqua-acupuncture with Cistanches Herba infusion solution, we used Cistanches Herba infusion solution(taken by water-alcohol method) put into Chung-wan(CV12) and Chok-Samni(S36) of BALB/c or C57BL/6 which are corresponding to human body. We observed the cytotoxicity, the effect on the expression of MMP-9 gene, the ability to control cancer cell proliferation, change of body weight, surviving number, MST, ILS, changes in amount of WBC, RBC, PLT, total protein, creatinine, glucose and LDH, weight of spleen, number of pulmonary colony, histological analysis on tissue metastasis of lung and liver, splenic cell proliferation, the expression of cytokine gene, the number of $CD4^+$, $CD8^+$, $CD19^+$ and NK cell, and concluded like this. The results were obtained as follows : 1. The cytotoxicity about B16-F10 cell line of $2^0$, $2^{-1}$, $2^{-2}$, $2^{-5}$ diluent groups in Cistanches Herba infusion solution treatment was inhibited significantly, compared with control group. 2. The cytotoxicity about HT1080 cell line of $2^0$, $2^{-1}$, $2^{-2}$, $2^{-3}$, $2^{-5}$, $2^{-8}$ diluent groups in Cistanches Herba infusion solution treatment was inhibited significantly, compared with control group. 3. The effect on expression of MMP-9 gene was decreased in all the sample groups, compared with control group. 4. The effect on the control-ability on the cancer cell proliferation showed cytotooicity significantly in $2^0$, $2^{-1}$, $2^{-2}$, $2^{-3}$, $2^{-4}$, $2^{-5}$ diluent groups. 5. S-180 cancer cell line transplants in BALB/c mice were inhibited significantly in weight increase in all the sample groups, compared with control group. The surviving number increased in almost sample groups, except one group put into Chok-Samni(S36) with 20% Cistanches Herba infusion solution treatment group that showed same number of the control group. 6. S-180 cancer cell line transplants in BALB/c mice showed high MST and ILS significantly in almost sample groups, compared with control group. But one group put into Chok-Samni(S36) with 20% Cistanches Herba infusion solution treatment group showed low MST and ILS than control group. 7. The sample group injected in vein with B16-F10 cancer cell line in C57BL/6 mice showed increased ILS compared with control group significantly in anti-metastasis test. 8. The sample group injected in vein with B16-F10 cancer cell line in C57BL/6 mice were increased significantly in the number of WBC and glucose, and decreased significantly in the amount of LDH, compared with control group. However, there's no significant increase or decrease in number of RBC, PLT, total protein and creatinine. 9. We couldn't find any significant relation in spleen weight of the sample group. 10. In pulmonary colony, sample group was decreased significantly, compared with control group. 11. Histological analysis of sample group inhivited compared with that of control group in both of lung and liver. 12. In immune system, all the sample groups showed having more relevancy to the effect on splenic cell proliferation than normal group. 13. The effect on cytokine gene expression of all the sample groups were increased than control group. 14. In flow cytometry there's no significant relation in number of $CD8^+$, $CD19^+$ cell, however, the number of $CD4^+$ cell and NK cell in sample groups were increased than in control group. Above the results showed that aqua-acupuncture of Cistanches Herba infusion solution has effects of anti-cancer, anti-metastasis and immune response improvement.

  • PDF

비소세포 폐암환자의 객담 내 ERCC1 발현정도와 cisplatin 복합화학요법 후 치료반응 (Relation between ERCC1 Expression in Sputum and Survival after Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer)

  • 양성우;최평락;류홍준;김진구;옥철호;장태원;정만홍
    • Tuberculosis and Respiratory Diseases
    • /
    • 제60권2호
    • /
    • pp.151-159
    • /
    • 2006
  • 목 적 : 폐암치료에 가장 널리 사용되는 cisplatin은 DNA와 결합하여 DNA 복제를 방해한다. 이렇게 손상된 부위를 복구하는 과정에 excision repair cross complementing gene 1 (ERCC1)이 작용한다. ERCC1이 활성화 되면, 정상세포는 DNA 손상을 줄일 수 있지만 종양세포의 경우 cisplatin의 효과는 감소하게 된다. 비소세포 폐암(non-small cell lung cancer, NSCLC) 환자에서 cisplatin을 포함하는 화학치료를 할 경우 예후인자로서 객담 ERCC1 정량측정의 의의를 조사하였다. 대상 및 방법 : 2001년 4월부터 2003년 8월 사이에 NSCLC로 진단되어 cisplatin과 taxane계(33명) 혹은 cisplatin과 gemcitabine(34명) 복합 화학치료를 받은 환자를 대상으로 하였다. 기관지 내시경검사를 실시한 후에 즉각 채취한 객담을 처리하여 c-DNA를 분리한 후, 객담속의 종양특이 유전자인 melanoma antigen gene (MAGE) 발현 여부는 RT-PCR로, ERCC1의 상대적 정량적 측정은 real-time PCR로 하였다. 환자의 치료반응 및 생존기간과 MAGE 발현여부 및 ERCC1의 발현정도와의 상관관계를 조사하였다. 결 과 : 객담에서 MAGE는 40.2%, ERCC1은 74.6%에서 발현되었다. ERCC1이 중앙값 이상인 경우와 미만인 군으로 나눠서 비교한 결과 ERCC1이 증가된 군의 중앙생존기간이 84주로 미만인 군의 44주보다 길었다(P=0.017). Taxane계를 사용한 군의 중앙생존기간이 79주로 gemcitabine 사용군의 47주에 비해 길었다(P=0.03). MAGE의 발현 여부는 생존기간과 유의한 관계는 없었으나, MAGE 발현군에서 ERCC1이 유의하게 증가되어 있었다(P=0.003). MAGE가 발현되지 않고 ERCC1이 증가된 군의 중앙생존기간은 103주로 그렇지 않은 군의 43주보다 길었고(P=0.008), MAGE가 발현된 경우는 두 군 간에 차이가 없었다(각각 62주 및 44주, P=0.348). 결 론 : NSCLC 환자의 객담에서 ERCC1을 정량 측정하는 것이 화학치료를 받는 환자의 생존기간을 예측하는 한 인자로 유용할 것으로 추정된다.

측두하악장애에서의 적외선 체열 촬영 검사의 유용성 (Infrared Thermography in the Assessment of Temporomandibular Joint Dysorder)

  • 남상건;구미숙;김양현;서정훈;신화용;최용민;김용철;이상철;이평복
    • The Korean Journal of Pain
    • /
    • 제20권2호
    • /
    • pp.163-168
    • /
    • 2007
  • Background: Temporomandibular joint disorder (TMD) is a group of musculoskeletal conditions characterized by pain in the pre-auricular area, limitation of jaw movement and palpable muscle tenderness. Thermography is a nonionizing, noninvasive diagnostic alternative for the evaluation of TMD. This study was conducted to evaluate the usefulness of thermography in the assessment of TMD. Methods: Thermography was conducted on the 61 patients who had been diagnosed with TMD, and on the 34 normal symptom-free volunteers. The temperature differences between opposite sides of the temporomandibular joint (${\Delta}T_{TMJ}$) and the masseter muscle (${\Delta}T_{MST}$) were calculated. The sensitivity and specificity of thermography was calculated at the cut off values of 0.2, 0.3, and $0.4^{\circ}C$. Results: In the patient group, the ${\Delta}T_{TMJ}$ was $0.42{\pm}0.38^{\circ}C$ and the ${\Delta}T_{MST}$ was $0.38{\pm}0.33^{\circ}C$, whereas in the control group the ${\Delta}T_{TMJ}$ was $0.10{\pm}0.07^{\circ}C$ and the ${\Delta}T_{MST}\;0.15{\pm}0.10^{\circ}C$. In addition, the patient group demonstrated a significantly lower level of thermal symmetry than the control group (P < 0.001) in both the temporomandibular joints and the masseter muscles. The sensitivity of thermography at the cut off values of 0.2, 0.3 and $0.4^{\circ}C$ was 67.2, 49.2, and 42.6% in the temporomandibular joint (TMJ) and 60.7, 49.2 and 37.7% in the masseter muscle, respectively. The specificity of thermography at the cut off values of 0.2, 0.3 and $0.4^{\circ}C$ was 88.2, 100, and 100% in the TMJ and 61.8, 91.2 and 100% in the masseter muscles, respectively. The accuracy of thermography at the cut off values of 0.2, 0.3 and $0.4^{\circ}C$ was 74.7, 67.4, and 63.2% in TMJ and 61.1, 64.2 and 60.0% in the masseter muscles, respectively. Conclusions: Temperature differences exist between the opposite sides of the TMD and masseter muscles in patients with TMD. Although the sensitivity of thermography in the diagnosis of TMD is low, it has high specificity in the evaluation of TMD, and is therefore applicable to patients with TMD.

반복 경두개자기자극술의 우울증 치료효과 및 최신동향에 대한 고찰 (Clinical Efficacy of Repetitive Transcranial Magnetic Stimulation for Treatment of Depression and Latest Trends in TMS Techniques)

  • 김신태;김혜원;김세주;강지인
    • 생물정신의학
    • /
    • 제24권3호
    • /
    • pp.95-109
    • /
    • 2017
  • 본 종설에서는 우울증에서의 rTMS 임상연구를 임상특성과 TMS 적용방법을 고려하여 체계적으로 고찰하였으며 새로운 TMS 치료기법에 대해 살펴보았다. rTMS는 항우울제에 반응이 적은 단극성 우울증 환자의 치료에 병용 혹은 단독요법으로 사용될 수 있는 안전하고 비침습적인 뇌조절술이다. rTMS는 고빈도 좌측 DLPFC, 저빈도 우측 DLPFC, 그리고 양측성 DLPFC 적용방법이 비슷한 수준으로 허위자극에 비해 유의하게 항우울효과를 가지고 있다. 그러나 치료저항성 단극성 우울증에 대한 항우울효과 크기는 작았다. 또한 정신병적 증상이 동반된 우울증의 치료와 양극성 장애의 우울삽화에 대해서는 치료효과가 불분명하다. 기존 rTMS의 항우울효과 크기는 작은 정도로 그 효과를 증진시키기 위해 고용량의 자극, 보다 깊이 자극할 수 있는 코일을 이용한 rTMS 치료, 표적영역에 보다 정확하게 코일을 위치시키는 신경항법 등을 이용한 TMS 적용 등의 새로운 시도들이 진행되고 있다. 또한 세타돌발자극과 자기경련치료와 같은 새로운 치료기법을 이용한 시도가 우울증 치료의 새로운 장을 열고 있다. 비록 현재까지 rTMS의 항우울효과가 만족할 만한 수준은 아니지만 임상양상을 세분화한 치료적용과 개선된 치료기법의 적용 등을 통해 더 많은 후속 연구가 이루어질 필요가 있다. 또한 여러 형태의 TMS 기법에 대해 잘 설계된 허위자극에 대한 통제연구뿐만 아니라 서로의 비교연구를 통해 우울증 치료에서의 근거수준을 높일 수 있을 것으로 기대한다.

한국형 Streptococcus mutans의 분리 및 동정 (Isolation and Identification of Korean type Streptococcus mutans)

  • 현성희;장성렬;최영길
    • 미생물학회지
    • /
    • 제27권3호
    • /
    • pp.250-258
    • /
    • 1989
  • 한국사람으로부터 치마우식증의 원인규능로 알려진 S. mutans를 분리, 동정하였고, 이들과 기존의 실험실균주간의 생리 및 생화학적 특성과 이들이 합성하는 다당류의 구성당을 비교하였다. 분리배지인 MS. MST와 선택배지인 MSP. MSPT. MSB 그리고 MSBT에서 모두 생장하고, mannitol dehydrogenase를 분비하는 균주 108, 110 및 120이 S. mutans로 분리, 동정되었다. 분리균주와 기존의 실험실균주간의 생리 및 생화학적 특성을 비교한 결과, 본 연구에서 분리한 3균주 모두 기존의 실험실균주와는 달리 hippuraterktnqnsgogyth를 가지고 있었다. 또한 균주 108은 lactose 발효 능력이, 균주 110은 sorbitol, lactose, inulin, melibiose, raffinose 발효능력이 , 균주 120은 inulin. raffinose 발효능력이 없는 것으로 나타나 기존의 실험 실균주와는 물론 이들 각각도 다른 생리 및 생화학적 특성을 나타내었다. 상기의 결과와 같이 분리균주 108, 110 그리고 120은 생리, 생화학적 특성 및 자당으로부터 합성되는 glucan의 양에 있어서도 기존의 실험실균주와 다르게 나타나 이들을 각각 한국형 S. mutans KHC108, KHCH10, KHC120이라 명명하였다.

  • PDF

Clinical Outcomes of Basaloid Squamous Cell Carcinoma of the Esophagus: A Retrospective Analysis of 142 Cases

  • Zhang, Bai-Hua;Cheng, Gui-Yu;Xue, Qi;Gao, Shu-Geng;Sun, Ke-Lin;Wang, Yong-Gang;Mu, Ju-Wei;He, Jie
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권3호
    • /
    • pp.1889-1894
    • /
    • 2013
  • Background: Basaloid squamous cell carcinoma of the esophagus (BSCCE) is a rare and distinctive tumor with no standard treatment. This study aimed to explore treatment in relation to prognosis of the disease. Methods: A total of 142 patients with BSCCE that underwent treatment in our hospital from March 1999 to July 2010 were retrospectively analyzed. All patients received surgery, 42 postoperative radiotherapy and 28 patients chemotherapy. Results: There were 26 patients included in stage I, 60 in stage II, 53 in stage III and 3 in stage IV. The clinical symptoms and macroscopic performances of BSCCE did not differ from those of typical esophageal squamous cell carcinoma. Among 118 patients receiving endoscopic biopsy, only 12 were diagnosed with BSCCE. The median survival time (MST) of the entire group was 32 months, with 1-, 3- and 5-year overall survival (OS) of 81.4%, 46.8% and 31.0%, respectively. The 5-year OS of stage I and II patients was significantly longer than that of stages III/IV, at 60.3%, 36.1% and 10.9%, respectively (p<0.001, p=0.001). The MST and 5-year OS were 59.0 months and 47.4% in patients with tumors located in the lower thoracic esophagus, and 27.0 months and 18.1% in those with lesions in the upper/middle esophagus (p=0.002). However, the survival was not significantly improved in patients undegoing adjunctive therapy. Multivariate analysis showed TNM stage and tumor location to be independent prognostic factors. Furthermore, distant metastasis was the most frequent failure pattern, with a median recurrence time of 10 months. Conclusion: BSCCE is an aggressive disease with rapid progression and a propensity for distant metastasis. It is difficult to make a definitive diagnosis via preoperative biopsy. Multidisciplinary therapy including radical esophagectomy with extended lymphadenectomy should be recommended, while the effectiveness of radiochemotherapy requires further validation for BSCCE.